Evidence map›Paper›PMID 28344232›Full record

ReviewNanomaterials (Basel, Switzerland)2014

Mechanisms Underlying Cytotoxicity Induced by Engineered Nanomaterials: A Review of

Daniele R Nogueira, Montserrat Mitjans, Clarice M B Rolim, M Pilar Vinardell

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.The American journal of tropical medicine and hygiene · 2017
    Article
  11. Biocompatibility assessment of SiOIET nanobiotechnology · 2017
    Article
  12. Article
  13. Challenges and Advances in Nanotoxicology.Nanomaterials (Basel, Switzerland) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Daniele R NogueiraDepartamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, RS, 97105-900, Brazil. daniele.rubert@gmail.com.
Montserrat MitjansDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona 08028, Spain. montsemitjans@ub.edu.
Clarice M B RolimDepartamento de Farmácia Industrial, Universidade Federal de Santa Maria, Santa Maria, RS, 97105-900, Brazil. clarice.rolim@gmail.com.
M Pilar VinardellDepartament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona 08028, Spain. mpvinardellmh@ub.edu.
Consejo Superior de Investigaciones Científicas · ESUniversidade Federal de Santa Maria · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered nanomaterials are emerging functional materials with technologically interesting properties and a wide range of promising applications, such as drug delivery devices, medical imaging and diagnostics, and various other industrial products. However, concerns have been expressed about the risks of such materials and whether they can cause adverse effects. Studies of the potential hazards of nanomaterials have been widely performed using cell models and a range of

Indexed as

cell culturecytotoxicityin vitro methodsnanomaterialsnanosafety

Identifiers

PMID28344232
PMCPMC5304664
OpenAlexW2133522926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.